{
  "id": 15873850,
  "title": "Ontario drug funding decision leaves cancer patients disappointed, with few options",
  "url": "https://urgent.news/2026/10/21/ontario-drug-funding-decision-leaves-cancer-patients-disappointed-15873850",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-10-21T10:04:18.000Z",
  "source": {
    "name": "CityNews",
    "slug": "citynews",
    "url": "https://toronto.citynews.ca/2026/10/21/ontario-drug-funding-cancer-ohip/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Sabrina Apitz-Grossman was told 13 months ago that she had about 12 to 18 months to live. A rare form of cancer in the 31-year-old’s knee had metastasized, spreading to her lungs. She has undergone radiotherapy, chemotherapy and surgeries, though the synovial sarcoma couldn’t be fully removed. Apitz-Grossman’s doctors are recommending a treatment approved in […]",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Global News",
        "title": "Ontario drug funding decision leaves cancer patients disappointed, with few options",
        "url": "https://urgent.news/2026/10/21/ontario-drug-funding-decision-leaves-cancer-patients-disappointed-15887790",
        "published": "2026-10-21T12:13:30.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}